Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea Before and After Treatment With CPAP.

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00360659

Enrollment

Registered

2006-08-04

Start date

2004-02-29

Completion date

2005-02-28

Last updated

2008-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Obstructive sleep Apnea, Hypertension, Vasoactive hormones

Brief summary

We wanted to test the hypothesis that treatment with continuous positive airway pressure reduces nocturnal hypoxia and thereby affecting levels of vasoactive hormones leading to a fall in blood pressure patients with obstructive sleep apnea.

Interventions

DEVICEContinuous Positive Airway Pressure

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Age between 20 and 65 years * Obstructive sleep apnea * Hypertension or normal blood pressure

Exclusion criteria

* Drug or alcohol abuse * Pregnancy * History or clinical signs of disease in the heart, lungs, brain,liver, kidneys or endocrine organs * Diabetes

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026